slender medical ultrasound without limits. 2 confidential introduction founded 2007. headquarters...
TRANSCRIPT
Slender MedicalSlender MedicalUltrasound Without Limits
Confidential2
IntroductionIntroduction
Founded 2007. Headquarters – Herzliya, Israel
Technology: Non-invasive excess-fat removal using high intensity focused ultrasound
Market: Aesthetic market, clinics of plastic surgeons and dermatologists, medical SPAs
Large market opportunity: $8 B
Launch in 2010
Exciting near term exit prospect
Experienced, multi-disciplinary team
Strong IP
Developmental phase: Preclinical phase
Confidential3
Chin LiposuctionChin LiposuctionBefore After
Results obtained by standard liposuction
Confidential4
Large Market OpportunityLarge Market Opportunity
Up to 80% of all women over the age of 20 struggle with excess fat
495,000 potential professional users WW (source: M. Moretti, Medical Insights Inc.)
45,000 dermatologists, plastic surgeons
(150,000 SPA, paramedical)
300,000 other physician specialties (15%)
Estimated end user price $90,000
Total market opportunity: $8 B (Only for the capital part. Consumables will create additional revenue)
Confidential5
Surgical vs. Nonsurgical Surgical vs. Nonsurgical ProceduresProcedures
Liposuction total expenditure:$1.4 B
AAmerican Society for Aesthetic Plastic Surgery, 2007
Confidential6
ProductProduct Ultrasonic elements applied to the
treated area Focused ultrasound for breaking
down adipose tissue Through transmission ultrasound
for monitoring the treatment process
Treatment and monitoring are performed in a closed loop
Ultrasonic transmission is performed parallel to the skin.
Optional several sizes of hand held probe
Short time to market (Launch in 2010)
Confidential7
Technology BenefitsTechnology Benefits
Skin parallel transmission. Safer
avoiding bone pain
preventing transmission of acoustic energy to internal organs
Ability to treat organs that cannot be treated by the competitors (chin and arms)
Temperature feedback. Higher efficacy & Safer
Tissue (muscle/fat) differentiation. Safer
Several probe designs allowing treatment of both large and small areas such as chin and arms. More treatment opportunities for the physician
Confidential8
TeamTeam Dr. Liat Tsoref, Founder and CEO
EarlySense – Director of BD; Sunlight Medical (bone assessment ultrasound)- VP R&D; PhD in Physics, TAU
Prof. Haim Azhari, Founder and CTA
Researcher in the Technion
Mr. Gregory Krasnov, R&D Eng.
MSc, Ultrasound specialist, JetGuide Ltd., Technion
Yossi Gross, Founder and Consultant
Serial entrepreneur (VisionCare, BioControl, TransPharma, BrainsGate, Beta-O2 etc.)
Dr. Amiram Borenstein, Consultant
MD, MSc, Plastic and Aesthetic Surgeon
Confidential9
Objective - InvestmentObjective - Investment
Investment to date:
Rainbow Medical Ltd: $ 1,000,000
"A" Round Target $ 2M
A-Round UOP Clinical study, phase I and II
Development of a beta prototype
CE clearance
Confidential10
SummarySummary
Body shaping is a promising market with very high growth potential
Short time to market – LAUNCH in 2010
Multidisciplinary team with many years of experience in the field of ultrasound
A unique and proprietary technology
The combination of focused ultrasound treatment and monitoring abilities will turn Slender Medical into a leader in the body shaping market